“Alkyl-phospholipids and cell cycle check point inhibitor induce antineoplastic effects in breast cancer cells: Evidence from in vitro investigations”, CRM, vol. 2, no. 1, pp. 1–10, Jul. 2025, doi: 10.63626/xkbx3b64.